Skip to main content

67 Results for “IDE trial”

GORE® EXCLUDER® Device Reaches Significant Milestone

Proven device for endovascular aneurysm repair (EVAR) reaches 250,000 patients worldwide

Aug 22, 2017

GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF

CAUTION: Investigational device. Limited by United States law to investigational use.

Nov 1, 2022

Gore Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft

Results of early cannulation clinical trial presented at the 2013 VEITHsymposium

Nov 19, 2013

THE GORE RELIEF CLINICAL STUDY BEGINS RANDOMIZING PATIENTS TO EVALUATE PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF

CAUTION: Investigational device. Limited by United States law to investigational use.

Oct 15, 2023